Details of the SBP
| General Information of Synthetic Binding Protein (SBP) (ID: SBP003139) | ||||||
|---|---|---|---|---|---|---|
| SBP Name |
Monobody BMS-986192
|
|||||
| Synonyms |
Monobody BMS-986192
|
|||||
| Design Method | Traditional methods (Site-directed mutagenesis and/or Directed evolution) | |||||
| Highest Status | Research | |||||
| Protein Scaffold Information of This SBP | ||||||
|---|---|---|---|---|---|---|
| Scaffold ID | PS047 | [1] , [2] | ||||
| Scaffold Name | Monobody | |||||
| Scaffold Class | Non-Antibody | |||||
| Fold Type | Beta-Sheets + Loops | |||||
| Binding Target(s) of This SBP (BTS) |
|---|
| BTS Name | Details | Mechanism | Application | Affinity | Research Organization | Ref |
|---|---|---|---|---|---|---|
| Programmed cell death 1 ligand 1 | Binder | Molecular imaging of PD-L1 expression | N.A. | University of Groningen | [1] , [2] | |
| Clinical Trial Information of This SBP | ||||||
|---|---|---|---|---|---|---|
| NCT03520634 | Click to show the Detail | |||||
| Indication | Melanoma | |||||
| Phase | Not Applicable | |||||
| Title | PD-L1 PET Imaging in Melanoma Patients | |||||
| Status | Completed | |||||
| Sponsor | University Medical Center Groningen | |||||
| NCT03843515 | Click to show the Detail | |||||
| Indication | Oral Cavity Squamous Cell Carcinoma | |||||
| Phase | Phase I | |||||
| Title | Safety and tolerability of neoadjuvant nivolumab for locally advanced resectable oral cancer, combined with [18F]BMS-986192 / [18F]-FDG PET imaging and immunomonitoring for response prediction | |||||
| Status | Recruiting | |||||
| Sponsor | VU University Medical Center | |||||
| References |
|---|